Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Datascope Corporation (NasdaqNM:DSCP)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Upcoming Events
Oct  1Dividend payment of $0.05
Location
14 Philips Parkway
Montvale, NJ 07645
Phone: (201) 391-8100
Fax: (201) 265-8562
Employees (last reported count): 1,350
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 31%
·Over the last 6 months:
 · 15 insider sells; 314.0K shares
  (6.4% of insider shares)
·Institutional: 71% (103% of float)
(229 institutions)
·Net Inst. Buying: 268.0K shares (+2.49%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Datascope Corporation is a diversified medical device company that manufactures and markets proprietary products for clinical health care markets in interventional cardiology and radiology, cardiovascular and vascular surgery, anesthesiology, emergency medicine and critical care. The Company is a pioneer in intra-aortic balloon pumping, or cardiac assist systems, and also manufactures and markets a broad line of physiological monitors designed to provide for patient safety and management of patient care. The Company's vascular sealing products have revolutionized the technology that is used to seal arterial punctures to stop bleeding after catheterization procedures. The Company's InterVascular, Inc. subsidiary manufactures and distributes a proprietary line of knitted and woven polyester vascular grafts and patches for reconstructive vascular and cardiovascular surgery, while it is also involved in the life science research market through its newly formed subsidiary, Genisphere, Inc.
More from Market Guide: Expanded Business Description

Financial Summary
Datascope Corporation manufactures proprietary products for interventional cardiology, anesthesiology, cardiovascular and vascular surgery. For the fiscal year ended 6/30/01, revenues rose 4% to $312.8 million. Net income rose 4% to $34.2 million. Revenues reflect higher patient monitoring sales and increased international demand for InterGard(R) Silver. Higher income was partially offset by the absence of a $3.8 million gain on the sale of technology.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Lawrence Saper, 72
Chairman, and CEO
$4.6M$1.9M
Murray Pitkowsky, 69
Sr. VP, Sec.
377K272K
Leonard Goodman, 56
VP, CFO and Treasurer
427K--  
S. Arieh Zak, 39
VP - Regulatory Affairs and Corp. Counsel
363K40K
James Cooper, 49
VP of HR
--  --  
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:DSCPAs of 31-Aug-2001
Price and Volume
52-Week Low
on 1-Dec-2000
$30.813
Recent Price$42.01 
52-Week High
on 18-July-2001
$46.93 
Beta0.28 
Daily Volume (3-month avg)32.5K
Daily Volume (10-day avg)29.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+17.1%
52-Week Change
relative to S&P500
+57.1%
Share-Related Items
Market Capitalization$621.5M
Shares Outstanding14.8M
Float10.2M
Dividends & Splits
Annual Dividend (indicated)$0.20 
Dividend Yield0.48%
Last Split: 3 for 1 on 6-Jan-1992
Per-Share Data
Book Value (mrq)$16.46 
Earnings (ttm)$2.22 
Earnings (mrq)$0.74 
Sales (ttm)$20.27 
Cash (mrq)$2.58 
Valuation Ratios
Price/Book (mrq)2.55 
Price/Earnings (ttm)18.91 
Price/Sales (ttm)2.07 
Income Statements
Sales (ttm)$312.8M
EBITDA (ttm)$45.8M
Income available to common (ttm)$34.2M
Profitability
Profit Margin (ttm)10.9%
Operating Margin (ttm)14.6%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)11.41%
Return on Equity (ttm)14.61%
Financial Strength
Current Ratio (mrq)3.50 
Debt/Equity (mrq)0 
Total Cash (mrq)$38.2M
Short Interest
As of 8-Aug-2001
Shares Short84.0K
Percent of Float0.8%
Shares Short
(Prior Month)
29.0K
Short Ratio2.00 
Daily Volume42.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.